SCHEMBL7669205

SCHEMBL7669205

N=C(N)c1ccc(C(=O)Oc2ccc(S(=O)(=O)NCCC(=O)O)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TMPRSS15 P98073 8/20 0.52
F2 P00734 6/20 0.52
TMPRSS6 Q8IU80 4/20 0.52
PRSS1 P07477 5/20 0.49
ALDH1A1 P00352 1/20 0.45
MEP1B Q16820 1/20 0.45
ADAMTS4 O75173 1/20 0.44
MMP2 P08253 1/20 0.44
MMP13 P45452 1/20 0.44
MMP14 P50281 1/20 0.44
ADAMTS5 Q9UNA0 1/20 0.44
KLK1 P06870 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7670310 1.00 TMPRSS15 (0.52) TMPRSS15F2TMPRSS6PRSS1ALDH1A1
SCHEMBL7670445 0.88 TMPRSS6 (0.51) TMPRSS15F2TMPRSS6PRSS1MMP2
SCHEMBL7670690 0.88 TMPRSS6 (0.51) TMPRSS15F2TMPRSS6PRSS1MMP2
SCHEMBL7669940 0.86 MMP2 (0.55) ALDH1A1MEP1BADAMTS4MMP2MMP13
Acetic Acid SCHEMBL7663094 0.84 TMPRSS6 (0.55) TMPRSS15F2TMPRSS6PRSS1KLK1
Acetic Acid SCHEMBL7667840 0.84 TMPRSS6 (0.55) TMPRSS15F2TMPRSS6PRSS1KLK1
SCHEMBL7665182 0.78 PRSS1 (0.56) TMPRSS15PRSS1
SCHEMBL4619647 0.78 MEP1B (0.57) F2TMPRSS6ALDH1A1MEP1BMMP2
SCHEMBL8409042 0.78 LMNA (0.60) F2TMPRSS6ALDH1A1MMP2
SCHEMBL7665205 0.77 F2 (0.58) TMPRSS15F2TMPRSS6PRSS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US claimed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP claimed
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed